Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 2 completed trials

    Completion Rate
    100%(2/2)
    Active Trials
    0(0%)
    Results Posted
    100%(2 trials)

    Phase Distribution

    Early Phase 1
    2
    67%

    Phase Distribution

    2

    Early Stage

    0

    Mid Stage

    0

    Late Stage

    Phase Distribution2 total trials
    Early Phase 1First-in-human
    2(100.0%)

    Highest Phase Reached

    Early Phase 1

    Trial Status & Enrollment

    Completion Rate

    100.0%

    2 of 2 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    3

    all time

    Status Distribution
    Completed(2)
    Other(1)

    Detailed Status

    Completed2
    unknown1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    3
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Early Phase 1

    Trials by Phase

    Early Phase 12 (100.0%)

    Trials by Status

    unknown133%
    completed267%

    Recent Activity

    0 active trials
    Showing 3 of 3
    completedearly_phase_1

    Inhibition of Oral Tumorigenesis by Antitumor B

    NCT04278989
    completedearly_phase_1

    Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer

    NCT03459729
    unknown

    Pharmacokinetics Study of Antitumor B in Healthy Volunteers

    NCT04230057

    Clinical Trials (3)

    Showing 3 of 3 trials
    NCT04278989Early Phase 1

    Inhibition of Oral Tumorigenesis by Antitumor B

    Completed
    NCT03459729Early Phase 1

    Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer

    Completed
    NCT04230057

    Pharmacokinetics Study of Antitumor B in Healthy Volunteers

    Unknown

    All 3 trials loaded

    Drug Details

    Intervention Type
    Varies by study
    Total Trials
    3